Ye Zhou

2.1k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

Ye Zhou is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Oncology. According to data from OpenAlex, Ye Zhou has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 18 papers in Gastroenterology and 15 papers in Oncology. Recurrent topics in Ye Zhou's work include Gastrointestinal Tumor Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (15 papers) and Sarcoma Diagnosis and Treatment (7 papers). Ye Zhou is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (15 papers) and Sarcoma Diagnosis and Treatment (7 papers). Ye Zhou collaborates with scholars based in China, United States and Ethiopia. Ye Zhou's co-authors include Jeremy O. Jones, Yingqiang Shi, Eric C. Bolton, Biqiang Zheng, Ziwen Long, Yanong Wang, Xianghuo He, Chunyang Bao, Yan Li and Jie Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ye Zhou

48 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer

2016 580 citations Jie Chen, Yan Li et al. Cancer Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ye Zhou China	16	905	731	445	253	175	52	1.5k
Trisha Dwight Australia	23	514 0.6×	588 0.8×	151 0.3×	55 0.2×	508 2.9×	42	1.6k
Takeaki Fukuda Japan	16	343 0.4×	217 0.3×	292 0.7×	70 0.3×	250 1.4×	45	988
Badreddin Edris United States	11	390 0.4×	269 0.4×	259 0.6×	61 0.2×	57 0.3×	17	951
Hongying Zhang China	20	402 0.4×	285 0.4×	751 1.7×	29 0.1×	151 0.9×	83	1.3k
Gabriella Gaudioso Italy	16	369 0.4×	228 0.3×	156 0.4×	86 0.3×	114 0.7×	29	778
Kyung Han Nam South Korea	14	227 0.3×	154 0.2×	346 0.8×	53 0.2×	137 0.8×	46	832
Chunlu Tan China	18	512 0.6×	405 0.6×	296 0.7×	61 0.2×	461 2.6×	87	1.4k
Paolo Cotzia United States	17	364 0.4×	272 0.4×	439 1.0×	18 0.1×	104 0.6×	34	1.1k
Huiying He China	20	702 0.8×	285 0.4×	537 1.2×	22 0.1×	148 0.8×	63	1.2k
Rong-Zhen Luo China	20	737 0.8×	346 0.5×	230 0.5×	23 0.1×	216 1.2×	40	1.2k

Countries citing papers authored by Ye Zhou

Since Specialization

Citations

This map shows the geographic impact of Ye Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Zhou more than expected).

Fields of papers citing papers by Ye Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Zhou. The network helps show where Ye Zhou may publish in the future.

Co-authorship network of co-authors of Ye Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Zhou. A scholar is included among the top collaborators of Ye Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Zhou. Ye Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Minjun, Junling Gao, Zhi‐Xuan Li, et al.. (2025). Clusterin Drives Fiber Endocytosis by Mesothelial Cells to Resolve Liver Fibrosis. Gastroenterology. 170(3). 569–583.

Qiu, Haibo, Zhiyan Liang, Jing Yang, et al.. (2025). Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research. Signal Transduction and Targeted Therapy. 10(1). 361–361.

Qiu, Haibo, Zhiwei Zhou, Ye Zhou, et al.. (2024). Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and paraganglioma.. Journal of Clinical Oncology. 42(16_suppl). 11502–11502. 9 indexed citations

Wang, Zheng, Yunyun Wang, Jiachao Xiong, et al.. (2023). Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 10. 1121340–1121340. 7 indexed citations

Zhang, Qi, Ye Zhou, Lijie Song, et al.. (2023). China special issue on gastrointestinal tumors‐Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study. International Journal of Cancer. 153(11). 1885–1893. 4 indexed citations

Sukrithan, Vineeth, Jennifer A. Sipos, Ye Zhou, et al.. (2023). Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib. SHILAP Revista de lepidopterología. 2023. 1–4. 2 indexed citations

Jiang, Aimin, Ye Zhou, Juan Lü, et al.. (2023). Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells. 12(3). 349–349. 23 indexed citations

Li, Jiazheng, Hui Zhu, Chunhui Shou, et al.. (2023). CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors. European Radiology. 34(6). 3659–3670. 1 indexed citations

Li, Jian, Shirong Cai, Yongjian Zhou, et al.. (2022). Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study. Clinical Cancer Research. 28(16). 3425–3432. 12 indexed citations

10.

Jiang, Aimin, Ye Zhou, Wenliang Gong, et al.. (2022). CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative Medicine and Cellular Longevity. 2022(1). 5910575–5910575. 38 indexed citations

11.

Tong, Youzhi, et al.. (2021). Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19. Cancer Research. 81(13). 1–1.

12.

Nabhan, Fadi, Rulong Shen, Amit Agrawal, et al.. (2021). Pembrolizumab in a Patient with Treatment‐Naïve Unresectable BRAF‐Mutation Negative Anaplastic Thyroid Cancer. SHILAP Revista de lepidopterología. 2021(1). 5521649–5521649. 5 indexed citations

13.

Zhou, Ye, Guohua Yang, Siying He, et al.. (2019). Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clinica Chimica Acta. 492. 37–44. 91 indexed citations

14.

Zhou, Ye, Xuebin Wang, Xueping Qiu, et al.. (2018). CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 42(6). 529–541. 34 indexed citations

15.

Wu, Shuang, Ye Zhou, Haiying Hua, et al.. (2018). Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma. BMC Cancer. 18(1). 997–997. 15 indexed citations

16.

Zhang, Xinhua, Ye Zhou, Xin Wu, et al.. (2018). Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study. European Journal of Surgical Oncology. 45(3). 318–323. 6 indexed citations

17.

Zhang, Shuai, Xuebin Wang, Chenling Xiong, et al.. (2017). Polymorphism in ERCC1 confers susceptibility of coronary artery disease and severity of coronary artery atherosclerosis in a Chinese Han population. Scientific Reports. 7(1). 6407–6407. 3 indexed citations

18.

Chen, Jie, Yan Li, Qiupeng Zheng, et al.. (2016). Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Letters. 388. 208–219. 580 indexed citations breakdown →

19.

Zhou, Ye, et al.. (2014). Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: A prospective randomised trial in China. European Journal of Cancer. 50(10). 1772–1778. 76 indexed citations

20.

Huang, Kai, et al.. (2013). Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution. The American Journal of Surgery. 207(6). 847–854. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact